Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023)

Tectonic Therapeutic (TECX) has reported Non-Current Debt for 3 consecutive years, with $15.4 million the latest figure, recorded in Q1 2023.

• In Q1 2023, Non-Current Debt rose 2.24% year-over-year to $15.4 million; the TTM figure through Mar 2023 stood at $15.4 million (up 2.24% YoY), while the FY2022 annual figure was $15.3 million, up 2.21% from the prior year.
• Non-Current Debt improved to $15.4 million in Q1 2023 per TECX's latest filing, from $15.3 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $15.4 million in Q1 2023 and bottomed at $14.9 million in Q4 2021.
• Historically, Non-Current Debt has averaged $15.2 million across 3 years, with a median of $15.2 million in 2022.
• Annual changes were most pronounced in 2022 — Non-Current Debt gained 2.21% — and 2023, when it rose 2.24%.
• Tectonic Therapeutic's Non-Current Debt stood at $14.9 million in 2021, then rose by 2.21% to $15.3 million in 2022, then rose by 0.52% to $15.4 million in 2023.
• Business Quant data shows TECX's Non-Current Debt at $15.4 million in Q1 2023, $15.3 million in Q4 2022, and $15.2 million in Q3 2022.